Percutaneous sclerotherapy for head and neck lymphatic malformations in neonates and infants ≤ 12 months of age .

Michael Travis CatonMadhavi DuvvuriAmanda Baker Eric R Smith Kazim H Narsinh Matthew Robert Amans Steven W HettsRandall T HigashidaDaniel L CookeChristopher F Dowd

Published in: Journal of neurointerventional surgery (2022)

Percutaneous sclerotherapy is a safe and effective treatment for symptomatic LM of the head and neck in neonates and infants. Treatment strategy and management of recurrent symptoms requires consensus from an experienced, multidisciplinary team.

Keyphrases

minimally invasive
lymph node
ultrasound guided
palliative care
depressive symptoms
clinical practice
replacement therapy
smoking cessation